• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

The New USP <1231>
Water for Pharmaceutical Purposes

a detailed Overview

>>> ORDER NOW

Award for the
GMP Compliance Adviser

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".


GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.


2. GDP Audit Checklist
More than 700 questions with reference to regulations.


3. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.


4. Industry Guide to handle OOX Test Results
Every single step of the OOX process.


5. The New USP <1231>: Water for Pharmaceutical Purposes
A compact overview of the contents of the new version of USP <1231>.


>>> More Downloads

News about GMP/cGMP

2018-03-02

EU/US: MRA on Inspections – Four More Member States Added

On 1 March 2018, the FDA listed four additional recognised authorities under Article 7 of the Sectoral Annex for Pharmaceutical Good Manufacturing Practices (GMPs). This confirms the capability of the following four European Member States to carry out GMP inspections at a level equivalent to the US:

 

  • Greece, National Organisation for Medicines
  • Hungary, National Institute of Pharmacy and Nutrition
  • The Czech Republic, State Institute for Drug Control
  • Romania, National Medicines Agency.

The US FDA now relies on their inspections instead of conducting own inspections. EMA notes that plans are on track for the MRA to be operational in all Members States by 15. July 2019.
On 1 November 2017, the FDA already confirmed the capability of the eight EU Member States Austria, Croatia, France, Italy, Malta, Spain, Sweden, and United Kingdom (as reported).

According to the US FDA, this is another unprecedented step towards more efficient global pharmaceutical manufacturing inspections.

The EMA has also updated the corresponding Q&A document which now contains 10 questions that more or less summarise the current state of the MRA on inspections.

Source:

FDA: Mutual Recognition Agreement
EMA: News and Updates

Comments
No comment has yet been written about this news.
 
 
Literature recommendation
GMP Compliance Adviser
Single User Licence (yearly subscription)